Review article : Blood conservation in cardiac surgery: can drugs help?

Cosgrove DM , Loop FD , Lytle BW et al. Determinants of blood utilisation during myocardial revascularisation . Ann Thorac Surg 1985; 40: 380-84.

Czer LS , Bateman TM , Gray RJ et al. Treatment of severe platelet dysfunction and haemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin . JACC 1987; 9: 1139-47.

Bachman F. , McKenna R. , Cole ER , Najafi H. The haemostatic mechanisms after open heart surgery. J Thorac Cardiovasc Surg 1975; 70: 76-85.

Trimble AS , Herst R. , Grady M. , Crookston JH Blood loss in open heart surgery. Arch Surg 1966; 93: 323-26.

Esposito RA , Culliford AT , Calvin SB , Thomas SJ , Lackner H. , Spencer FC The role of the activated clotting time in heparin administration and neutralisation for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 85: 174-85.

Harker LA Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 1446-48.

Mohr R. , Golan M. , Martinowitz U. , Rosner E. , Goor DA , Ramot B. Effect of cardiac operation on platelets. J Thorac Cardiovasc Surg 1986; 92: 434-41.

Dechavanne M. , Ffrench M. , Pages J. et al. Significant reduction in the binding of a monoclonal antibody (LYP18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation . Thromb Haemost 1987; 57: 106-109.

Harker LA , Malpass TW , Branson HE et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha granule release. Blood 1980; 56: 824-34.

Musial J. , Niewiarowski S. , Hershock D. , Morinelli TA , Colman RW , Edmunds LH Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 1985; 105: 514-22.

Miller RD , Bove JR Acquired immune deficiency syndrome and blood products. Anaesthesiology 1983; 58: 493-94.

Weiland AP , Daskal Y. , Kerman RH et al. AIDS prodrome in an apparently normal man following coronary bypass: new significance of postoperative bleeding. Texas Heart Institute Journal 1985; 12: 195-97.

Johnson RG , Rosenkrantz KR , Preston RA , Hopkins H. , Daggett WM The efficacy of postoperative autotransfusion in patients undergoing cardiac operations. Ann Thorac Surg 1983; 36: 173-79.

Mayer ED , Welsch M. , Tanzeem A. et al. Reduction of postoperative donor blood requirement by use of the cell separator. Scand J Thor Cardiovasc Surg 1985; 19: 165-71.

Hiratzka LH , Richardson JV , Brandt III B. et al. The effect of autologous blood salvage techniques upon bank blood usage and the cost of routine coronary revascularisation. Perfusion 1986; 1: 239-44.

Addonizio VP , Fisher CA , Jenkin BK , Strauss JF III , Musial JF , Edmunds LH Jr. Iloprost (ZK 36374), a stable analogue of prostacyclin preserves platelets during simulated extracorporeal circulation . J Thorac Cardiocasc Surg 1985; 89: 926-33.

Bunting S. , O'Grady J. , Fabiani JN et al. Cardiopulmonary bypass in man: effects of prostacyclin. In: Lewis PJ , O'Grady J eds. Clinical pharmacology of prostacyclin, New York: Raven Press, 1981: 181-93.

Walker ID , Davidson JF , Faichney A. , Wheatley DJ , Davidson KG A double blind study of prostacyclin in cardiopulmonary bypass surgery . Br J Haematol 1981; 49: 415-23.

Longmore DB , Bennett JG , Hoyle PM et al. Prostacyclin administration during cardiopulmonary bypass in man. Lancet 1981 ; i: 800-804.

Fish KJ , Sarnquist FH , van Steenis C. et al. A prospective, randomised study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovasc Surg 1986; 91: 436-42.

Malpass TW , Amory DW , Harker LA , Ivey TD , Williams DB The effects of prostacyclin infusion on platelet haemostatic function in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1984; 87: 550-55.

DiSesa VJ , Huval W. , Lelcuk S. et al. Disadvantages of prostacyclin infusion during cardiopulmonary bypass. A double blind study of 50 patients having coronary revascularisation . Ann Thorac Surg 1984; 38: 514-19.

Ruggeri ZM , Mannucci PM , Lombardi R. , Federici AB , Zimmerman TS Multimeric composition of factor VIII/von Willebrand's factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 1272-78.

Sakariassen KS , Cattaneo M. , van den Berg A. , Ruggeri ZM , Mannucci PM , Sixma JJ DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium . Blood 1984; 64: 229-36.

Mannucci PM , Pareti FI , Ruggeri ZM , Capitanio A. 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1977; i: 869-72.

Mannucci PM , Remuzzi G. , Pusineri F. et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uraemia. N Engl J Med 1983; 308: 8-12.

Kobrinsky NL , Israels ED , Gerrard JM et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders . Lancet 1984; i: 1145-48.

Kobrinsky NL , Letts M. , Patel LR et al. 1-desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. Ann Intern Med 1987; 107: 446-50.

Salzman EW , Weinstein MJ , Weintraub RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402-1406.

Steele PM , Fuster V. , Chesebro JH , Badimon L. , Gorlin R. The role of platelet inhibiting drugs in cardiovascular therapy. In: Rowlands DJ ed. Recent advances in cardiology No. 9, London : Churchill Livingstone, 1984:

Gerrard JM , Friesen LL Platelets. In: Poller L ed. Recent advances in blood coagulation, London: Churchill Livingstone, 1985 .

Chesebro JH , Clements IP , Fuster V. et al. A platelet inhibitor drug trial in coronary artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative graft patency. N Engl J Med 1982; 307: 73-78.

Teoh KH , Christakis GT , Weisel RD et al. Prevention of myocardial platelet deposition and thromboxane release with dipyridamole. Circulation 1986 ; 74 (Suppl. III): 145.

Teoh KH , Christakis GT , Weisel RD et al. Blood conservation with membrane oxygenators and dipyridamole . Ann Thorac Surg 1987; 44: 40-47.

Verstraete M. Clinical application of inhibitors of fibrinolysis . Drugs 1985; 29: 236-61.

Fritz H. , Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittel-Forschung 1983 ; 33: 479-94.

Fritz H. The target organs of aprotinin in vitro and in vivo. In: Dudziak R , Kirchhoff PG , Reuter HD , Schumann F eds. Proteolyse und Proteinaseninhibition in der Herz- und Gefäßchirurgie , Stuttgart: Schattauer, 1985: 143-54.

Reuter HD The stablising effect of Trasylol on platelet membranes. Proceedings of the VII International Congress on Thrombosis and Haemostasis (Abstract). Thromb Haemostasis 1979; 42: 298.

Tice DA , Worth MH , Clauss RH , Reed GH The inhibition of Trasylol of fibrinolytic activity associated with cardiovascular operations. Surg Gynec Obstet 1964; 119: 72-74.

Mammen EF Natural proteinase inhibitors in extracorporeal circulation. Annals of the New York Academy of Sciences 1968; 146: 754-61.

Köstering H. , Kirchhoff PG , Völker P. , Warmann E. , Koncz J. Untersuchungen der Blutgerinnungsveränderungen während und nach Operationen mit Hilfe der Herz-Lungen maschine. Thoraxchirurgie 1973 ; 21: 534-43.

Urban AE , Brecher A-M. , Popov-Cenic S. Blutungen nach intrakardialen opertiven Eingriffen im Säuglingsalter: klinische Relevanz und perioperative Therapie. In: Dudziak R , Kirchhoff PG , Reuter HD , Schumann F eds. Proteolyse und Proteinaseninhibition in der Herz- und Gefäßchirurgie , Stuttgart: Schattauer Verlag , 1985: 273-79.

Popov-Cenic S. , Kirchhoff PG , Hack G. , Kulzer R. , Olligs J. Prophylaktische Behandlung mit Antiplasmin (Aprotinin) vor, wahrend und nach Operationen am offenen Herzen bei Erwachsenen. Klinische Bedeutung und ein neues Behandlungskonzept . In: Blümel G , Haas S , eds. Microzirkulation und Prostaglandinstoffwechsel usw. Verhandlungsbericht der 25. Tagung der Deutschen Arbeitsgemeinschaft für Blutgerinnungforschung . Stuttgart: Schattauer Verlag, 1981: 211-19.

Reuter HD , Selbherr J. , Hannekum A. , Dalichau H. , Busse J. The effect of aprotinin on platelet counts and functions in the course of open heart surgery. The Thoracic and Cardiovascular Surgeon (Special Issue 1) 1984; 32: 87.

van Ooveren W. , Janssen Njg , Bidstrup BP et al. Effects of aprotinin on haemostatic mechanism in cardiopulmonary bypass. Ann Thorac Surg 1987; 44: 640-45.

Weisel RD , Charlesworth DC , Mickleborough LL et al. Limitations of blood conservation. J Thorac Cardiovasc Surg 1984; 88: 26-38.

Heimbecker RO , Clarke MS Limitations of blood conservation . J Thorac Cardiovasc Surg 1985; 89: 470 (letter and reply).

Royston D. , Bidstrup BP , Taylor KM , Sapsford RN The effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 1987; ii: 1289-91.

Bidstrup BP , Royston D. , Sapsford RN , Taylor KM Effect of aprotinin on need for blood transfusion in patients with septic endocarditis having open heart surgery. Lancet 1988; i: 366-67.

Taylor KM Prostacyclin therapy during cardiopulmonary bypass. Perfusion 1987; 2: 1-7.

Limet R. , David J-L. , Magotteaux P. , Larock M-P. , Rigo P. Prevention of aortacoronary bypass graft occlusion: beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double blind study. J Thorac Cardiovasc Surg 1987 ; 94: 773-83.